Oscillating Positive Expiratory Pressure Devices Market Size
| Study Period | 2021 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players_Devices_Market__Logo.webp "Oscillating Positive Expiratory Pressure (OPEP) Devices Market Major Players"){kind=logo}
*Disclaimer: Major Players sorted in no particular order |
Oscillating Positive Expiratory Pressure Devices Market Analysis
The oscillating positive expiratory pressure (OPEP) devices market is expected to register a CAGR of 5.3% over the forecast period.
The increased number of cases of chronic pulmonary diseases with the outbreak of the pandemic has impacted the market. According to a study published by the ERJ in October 2021, patients with prior influenza were at higher risk of developing severe COVID-19 and had a higher mortality rate than patients without a history of respiratory illness. Similarly, per a study published by the National Center for Biotechnology Information (NCBI) in July 2021, chronic respiratory diseases were common among patients with COVID-19. Increasing cases of respiratory diseases in the initial days of the pandemic propelled the demand for oscillating positive expiratory pressure devices as it is used to clear mucus from the lungs of individuals with respiratory illnesses.
Although there was a sharp rise in demand for OPEP devices initially, it has now reduced greatly now that the pandemic has ended.
However, the OPEP devices market is expected to maintain growth over the forecast period owing to growing cases of other respiratory diseases such as pneumonia and asthma.
For instance, according to a study published by the NCBI in June 2021, chronic respiratory diseases contribute significantly to the national, regional, and global burden of disease. The study also reported that morbidity and mortality from such conditions are estimated to be high in low- and middle-income countries. Similarly, as per the report published by Lung India in December 2021, the prevalence rate of chronic obstructive pulmonary disease (COPD) among males and females was 11.4% in India in 2021. Similarly, as per the ERS journal of 2021, it was estimated that around 36,580,965 Europeans suffered from COPD in 2020 and as per Mordor Intelligence analysis around 49,453,852 Europeans were expected to suffer from COPD in 2050.
Owing to such a high prevalence of COPD the researchers are also focusing on developing innovative and new devices for advanced treatment. For instance, as per another study published by the NCBI in January 2021, due to the increasing cases of COPD across the globe, the researchers were focusing on developing new advanced devices and novel surgical and bronchoscopic procedures. Therefore, such positive advancements and a high prevalence of respiratory diseases are anticipated to propel the demand for OPEP devices, thereby surging market growth.
Furthermore, the technological advancements related to OPEP devices are also pushing market growth. For instance, as per a study published by BMC Pulmonary Medicine in October 2021, currently, reusable OPEP devices are available that require regular cleaning and disinfection to prevent harboring of potentially pathogenic organisms. However, adherence to cleaning regimens for respiratory devices is often critical. Therefore, a prototype single-use OPEP device - 'UL-OPEP' was developed to mitigate the risk of pathogen contamination. Such technological advancements and innovations may create opportunities for the market, which in turn may encourage many new players to enter the market and drive growth.
On the other hand, a lack of skilled professionals is likely to hinder the market growth over the forecast period.
Oscillating Positive Expiratory Pressure Devices Market Trends
This section covers the major market trends shaping the Oscillating Positive Expiratory Pressure Devices Market according to our research experts:
COPD and Asthma Segment is Expected to Witness Largest Growth Over the Forecast Period
Asthma is the most common chronic respiratory disease affecting children globally. Asthma is a chronic (long-term) condition that affects the airways in the lungs. The airways are the tubes that carry air in and out of your lungs. The airways of asthma patients can sometimes become inflamed and narrow. This makes it difficult for air to flow out of the airways when exhaling. COPD is a group of lung diseases that make breathing difficult and worsen over time. The high prevalence of asthma and COPD across the globe is one of the major factors propelling the segment's growth.
For instance, per the journal published by the ERJ Open Research in August 2022, a study based on the ISAAC questionnaire reported a prevalence of bronchial asthma of 13.1% in children aged 11 to 16 years globally. It also reported that, globally, the prevalence of asthma in children was 10.2%. Similarly, as per a journal published by ScienceDirect in January 2022, the overall prevalence of asthma in Saudi Arabia was 14.2% in 2021.
Furthermore, per a report published by the CDC in July 2022, the overall prevalence rate of COPD in the United States in 2021 was more than 5.6%. The prevalence of COPD among individuals aged 5 to 29 years was found to range from 0.1% to 0.9%, increasing to 1.6% to 28.3% in the population aged 30 years in 2021. Such instances indicate that the demand for OPEP devices is anticipated to increase, propelling segment growth.
North America is Expected to Witness Largest Growth Over the Forecast Period
North America is expected to dominate the overall OPEP devices market over the forecast period. The growth is due to factors such as increasing cases of pediatric respiratory diseases and increasing research work. For instance, as per a report published by Asthma Canada in June 2021, more than 850,000 children under the age of 14 had asthma, thereby making it the most common chronic disease among children and the leading cause of both school absenteeism and hospitalization in Canada. Similarly, per a journal published by the CMAJ Group in May 2021, asthma is the most common chronic disease in children, with a prevalence of 15.0% to 25.0% in Canada.
Key product launches, high concentration of market players or manufacturer's presence, acquisition and partnerships among major players, and increasing cases of respiratory diseases in the United States are some of the factors driving the growth of the OPEP devices market in the country. For instance, as per an NCBI study published in August 2022, in the United States, the annual incidence of pneumonia is 24.8 cases per 10,000 adults, with higher rates as age increases.
Oscillating Positive Expiratory Pressure Devices Industry Overview
The global OPEP devices market is competitive and consists of very few major players. The competitive landscape includes an analysis of a few international as well as local companies which hold considerable market shares and are well-known, including AirPhysio, D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, and Smiths Medical, Inc. among others.
Oscillating Positive Expiratory Pressure Devices Market Leaders
-
Smiths Medical, Inc.
-
Monaghan Medical Corporation
-
R. Cegla GmbH & Co. KG
-
PARI GmbH
-
AirPhysio
*Disclaimer: Major Players sorted in no particular order
_Devices_Market___CL___New.webp "Oscillating Positive Expiratory Pressure (OPEP) Devices Market Concentration")
Oscillating Positive Expiratory Pressure Devices Market News
- in April 2021, Smiths Medical launched the acapella choice blue vibratory PEP therapy system. Acapella is designed to aid in removing secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
- In January 2021, AirPhysio, indicated for use as a Positive Expiratory Pressure (PEP) Device, received approval from the United States Food and Drug Administration.
Oscillating Positive Expiratory Pressure Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Rising Prevalence of Chronic Respiratory Diseases Across the Globe
- 4.2.2 Growing Technological Advancements
-
4.3 Market Restraints
- 4.3.1 Lack of Skilled Professionals
-
4.4 Porter's Five Force Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD Million)
-
5.1 By Product Type
- 5.1.1 Face Mask PEP Devices
- 5.1.2 Mouthpiece PEP Devices
- 5.1.3 Bottle PEP Devices
-
5.2 By Indication
- 5.2.1 COPD and Asthma
- 5.2.2 Bronchitis
- 5.2.3 Cystic Fibrosis
- 5.2.4 Others
-
5.3 By End-User
- 5.3.1 Hospital and Clinics
- 5.3.2 Ambulatory Surgical Centers
- 5.3.3 Others
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Rest of the World (ROW)
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 AirPhysio
- 6.1.2 Smiths Medical
- 6.1.3 D-R Burton Healthcare
- 6.1.4 Medica Holdings, LLC
- 6.1.5 Monaghan Medical Corporation
- 6.1.6 PARI GmbH
- 6.1.7 R. Cegla GmbH & Co. KG
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityOscillating Positive Expiratory Pressure Devices Industry Segmentation
An OPEP device refers to a device that uses Oscillating Positive Expiratory Pressure or OPEP to help clear secretions from the airways. People with chronic bronchitis, bronchiectasis, COPD, and cystic fibrosis often produce excessive mucus. As they exhale through the OPEP device, they can feel vibrations or 'pulses,' which loosen the mucus from the walls of the lungs, making it easier to cough up the secretions. The Oscillating Positive Expiratory Pressure (OPEP) Devices market is Segmented by Product Type (Face Mask PEP Devices, Mouthpiece PEP Devices, and Bottle PEP Devices), Indication (COPD and Asthma, Bronchitis, Cystic Fibrosis, and Others), End-User (Hospital and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World (ROW)). The report offers the value (in USD million) for the above segments.
| By Product Type | Face Mask PEP Devices | |
| Mouthpiece PEP Devices | ||
| Bottle PEP Devices | ||
| By Indication | COPD and Asthma | |
| Bronchitis | ||
| Cystic Fibrosis | ||
| Others | ||
| By End-User | Hospital and Clinics | |
| Ambulatory Surgical Centers | ||
| Others | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Rest of the World (ROW) |
Oscillating Positive Expiratory Pressure Devices Market Research FAQs
What is the current Oscillating Positive Expiratory Pressure (OPEP) Devices Market size?
The Oscillating Positive Expiratory Pressure (OPEP) Devices Market is projected to register a CAGR of 5.30% during the forecast period (2024-2029)
Who are the key players in Oscillating Positive Expiratory Pressure (OPEP) Devices Market?
Smiths Medical, Inc. , Monaghan Medical Corporation , R. Cegla GmbH & Co. KG , PARI GmbH and AirPhysio are the major companies operating in the Oscillating Positive Expiratory Pressure (OPEP) Devices Market.
Which is the fastest growing region in Oscillating Positive Expiratory Pressure (OPEP) Devices Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Oscillating Positive Expiratory Pressure (OPEP) Devices Market?
In 2024, the North America accounts for the largest market share in Oscillating Positive Expiratory Pressure (OPEP) Devices Market.
What years does this Oscillating Positive Expiratory Pressure (OPEP) Devices Market cover?
The report covers the Oscillating Positive Expiratory Pressure (OPEP) Devices Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Oscillating Positive Expiratory Pressure (OPEP) Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Oscillating Positive Expiratory Pressure (OPEP) Devices Industry Report
Statistics for the 2024 Oscillating Positive Expiratory Pressure (OPEP) Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Oscillating Positive Expiratory Pressure (OPEP) Devices analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
